(NASDAQ: KRRO) Korro Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.59%.
Korro Bio's earnings in 2025 is -$83,581,000.On average, 6 Wall Street analysts forecast KRRO's earnings for 2025 to be -$96,721,652, with the lowest KRRO earnings forecast at -$112,197,379, and the highest KRRO earnings forecast at -$81,589,558. On average, 5 Wall Street analysts forecast KRRO's earnings for 2026 to be -$79,486,444, with the lowest KRRO earnings forecast at -$118,394,054, and the highest KRRO earnings forecast at -$52,953,407.
In 2027, KRRO is forecast to generate -$98,207,915 in earnings, with the lowest earnings forecast at -$125,905,176 and the highest earnings forecast at -$59,150,083.